259 related articles for article (PubMed ID: 28165586)
41. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
[TBL] [Abstract][Full Text] [Related]
42. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
[TBL] [Abstract][Full Text] [Related]
43. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis.
Kohro S; Imaizumi H; Yamakage M; Masuda Y; Namiki A; Asai Y; Maruyama I
J Anesth; 2006; 20(1):11-6. PubMed ID: 16421670
[TBL] [Abstract][Full Text] [Related]
44. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
[TBL] [Abstract][Full Text] [Related]
45. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
46. Unsatisfactory Short-Term Neurodevelopmental Outcomes of Preterm Infants Who Received Polymyxin B-Immobilized Fiber Column-Direct Hemoperfusion for Septic Shock.
Nishizaki N; Shima T; Watanabe A; Obinata K; Shimizu T
Tohoku J Exp Med; 2021 Apr; 253(4):275-281. PubMed ID: 33896891
[TBL] [Abstract][Full Text] [Related]
47. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
48. Polymyxin B hemoperfusion: a mechanistic perspective.
Ronco C; Klein DJ
Crit Care; 2014 Jun; 18(3):309. PubMed ID: 25043934
[TBL] [Abstract][Full Text] [Related]
49. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
50. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
51. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
[TBL] [Abstract][Full Text] [Related]
52. Direct hemoperfusion using polymyxin-B immobilized fiber for severe septic patients with hematological disorders: a single-center analysis.
Mori M; Onaka T; Yonezawa A; Kitagawa T; Sasaki Y; Imada K
J Infect Chemother; 2014 Apr; 20(4):282-4. PubMed ID: 24485325
[TBL] [Abstract][Full Text] [Related]
53. Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX).
Shimizu T; Miyake T; Kitamura N; Tani M; Endo Y
Transfus Apher Sci; 2017 Oct; 56(5):682-688. PubMed ID: 28923774
[TBL] [Abstract][Full Text] [Related]
54. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
Taniguchi T; Sato K; Kurita A; Noda T; Okajima M
Minerva Anestesiol; 2013 Jul; 79(7):758-61. PubMed ID: 23635997
[TBL] [Abstract][Full Text] [Related]
56. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
[TBL] [Abstract][Full Text] [Related]
57. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
[TBL] [Abstract][Full Text] [Related]
58. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
59. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
